News Highlights

FDA Approval a Two-Edged Sword for Neurotech Vendors
The statutory mission of the U.S. Food and Drug Administration is to protect Americans from tainted foods and unsafe pharmaceuticals and medical devices, but in recent months the FDA has been accused of running interference for established makers of neurotech devices who are confronted with competitive products. In the most celebrated case, Plano, TX-based Advanced Neuromodulation Systems Inc. (ANS) openly accused giant medical device manufacturer Medtronic Inc. of manipulating the FDA to maintain a monopoly in the implantable pulse generator (IPG) market. ANS argues that Medtronic worked to torpedo an FDA ruling that would have fast-tracked approval of an ANS competitor to the Medtronic IPG. Click here to subscribe.

Functional Electrical Stimulation Converges in Cleveland
Neurotechnologists from all over the world met in Cleveland in June at the annual meeting of the International Functional Electrical Stimulation Society. Our report offers the highlights of the meeting and reviews the state of the art in this pioneering new field. Click here for full article.

Venture Capitalists Discuss Impediments to Funding
everal Los Angeles area venture capitalists offered their ideas on the status of funding for bioscience and medical device companies. In particular, they spoke of the relationship between a strong local venture capital community and biomedical industry. Click here to subscribe.

NIH Releases Program for Neurotechnology Research
The National Institutes of Health in early October released a new program announcement for Neurotechnology Research, Development, and Enhancement. The new initiative encourages multidisciplinary research efforts and involves several NIH institutes, including the National Institute of Mental Health, the National Institute on Deafness and Other Communication Disorders, National Institute of Child Health and Human Development, National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse, and the National Institute on Aging. Click here for full article.

Subscribe Now!

Neurotech Business Report is the premier publication serving the emeging market for neurotechnology. Launced in 2001, this authoritative newsletter brings you up-to-the-minute news and analysis of key developments in the neurotechnology industry. Our award-winning team of editors and analysts cover the companies, products, deals, financing activity, and promise of neurotech.

Each monthly issue of Neurotech Business Report brings you in-depth profiles of neurotech device manufacturers and research institutions. You'll learn who the key players are in this emerging market and the promising applications in health care, information processing, training, and virtual reality. Plus, your subscription entitles you to an e-mail alert service that brings you important news and event bulletins as they happen. And you'll get on-line and print editions of the newsletter at no additional cost, plus exclusive access to our database of neurotech companies and institutions.

What's in Neurotech Business Report

Application Areas
Editorial Features
  • Functional Electrical Stimulation
  • Neural Prostheses
  • Neural Networks
  • Magnetic Stimulation and Sensing
  • Brain Recording and Imaging
  • Neural/Silicon Hybrids
  • Rehabilitation
  • Sports Training
  • Computing
  • Virtual Reality
  • Man/Machine Interfaces
  • Psychotherapy
  • Pain Management
  • Aerospace
  • Company Profiles
  • Funding Opportunities
  • Venture Capital Deals
  • Regulatory Issues
  • Research Institute Profiles
  • Product Directions
  • Market Strategies
  • Conference Reports


site design by shalatdesign |